“Thanks for the information and support.”
General Field: Pharmacology
Position at the Time of Case Filing: Senior Scientist
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: New Jersey
Approval Notice Date: March 8th, 2017
Processing Time: 13 Days (Premium Processing Requested)
Just 13 days after North America Immigration Law Group (NAILG) filed an EB-1A (Alien of Extraordinary Ability) petition on behalf of a senior scientist from India, the USCIS approved his case. With extensive experience carrying out studies in the field of pharmacology, our client has met 3 out of the 10 EB1A criteria set by the USCIS. These are the criteria:
- Authorship of scholarly articles in the field, in professional journals, or other major media: We noted the 30 peer-reviewed scientific articles and 3 book chapters in our client’s name and demonstrated that this publication record is exemplary compared to that of his peers.
- Participation on a panel or individually, as a judge of the work of others in the same or a related field: By the time we were ready to file our client’s case, he had already conducted 60 peer reviews. We persuaded the USCIS that this frequent review activity showcased our client’s important standing in the field.
- Original contributions of major significance: We used our client’s citation count as proof that he has significantly contributed to the field of pharmacology. Thanks to Google Scholar, we confirmed that our client’s work had amassed 179 citations at the time of filing.
Besides the 3 criteria listed above, we also incorporated recommendation letters into our client’s EB1A petition. We helped our client handpick the recommenders, all of whom are experts in the field and familiar with his work. Not long after, our client returned with their signed letters that supported the approval of his EB1A petition. According to one of his recommenders: “[Client’s] work is thus very important for the breast cancer patients in the United States and around the world.”
As we were able to demonstrate the importance of our client’s work on drug delivery and formulation—important issues in understanding efficient methods for producing pharmaceutical drugs in the United States—the USCIS granted him EB1A petition approval. We congratulate him on this win and thank him for retaining us to help him and his dependent with their I-485 applications.
We are pleased to announce that North America Immigration Law Group has so far received over 7,500 EB-1A, EB-1B and EB-2 NIW approval notices. In 2015 and 2016, the approval rate is 97.9% for cases using our "Approval or Refund®" (money back guarantee) service and 96.9% for all cases.
As one of the leading U.S. immigration law firms providing the most comprehensive services focusing on EB-1/NIW petitions, we are proud to maintain our high approval rates with a large volume of approved cases.
Our staff keeps close track of the latest immigration trends and regulations of USCIS (U.S. Citizenship and Immigration Services), decisions of AAO (Administrative Appeal Office) and judicial review opinions. The massive collected materials contribute to the most convincing arguments and winning strategies of our firm for EB1A, EB1B, and NIW petitions.
Approval Notices: http://www.wegreened.com/eb1_niw_approvals
Success Stories: http://blog.wegreened.com/
Free evaluation email: email@example.com
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to: